Preview

Medical and Biological Problems of Life Activity

Advanced search

Clinical significance of determining trec and krec markers in dried blood spots in children with severe infectious diseases complicated by fatal outcome

https://doi.org/10.58708/2074-2088.2026-2(38)-20-25

Abstract

The article presents the results of a study of the levels of T-lymphocyte receptor DNA recombination products (TREC) and B-lymphocyte receptor DNA recombination products (KREC) in children with severe infectious diseases complicated by a fatal outcome. Data from 18 children who died from infections associated with immune mechanism disorders were analyzed. TREC and KREC levels were successfully determined in 11 children from neonatal screening records using real-time PCR. Significant variability in marker levels was established: the TREC copy number ranged from 250,0 to 29 988,0, and KREC – from 1 759,0 to 33 214,0 copies per 106 leukocytes. Cases of both reduced marker levels and marker levels within the normal range were identified. The lowest TREC levels were observed in children with thymic hypoplasia and sepsis (250,0 and 746,0 copies per 106 leukocytes, respectively). These data suggest the need for a differentiated approach to interpreting TREC and KREC levels in critically ill newborns, taking into account the multiple factors affecting immune status

About the Authors

E. A. Polyakova
ГУ «РНПЦ детской онкологии, гематологии и иммунологии»; УО «Белорусский государственный медицинский университет»
Belarus


O. L. Zobikova
ГУ «Республиканский научно-практический центр «Мать и дитя»»
Belarus


A N. Kupchinskaya
ГУ «Республиканский научно-практический центр детской онкологии, гематологии и иммунологии»
Belarus


I. S. Sakovich
ГУ «Республиканский научно-практический центр детской онкологии, гематологии и иммунологии»
Belarus


M. V. Belevtsev
ГУ «Республиканский научно-практический центр детской онкологии, гематологии и иммунологии»
Belarus


I. V. Naumchik
ГУ «Республиканский научно-практический центр «Мать и дитя»»
Belarus


References

1. Trends in Pediatric Primary Immunodeficiency: Incidence, Utilization, Transplantation, and Mortality / T. Eddens [et al.] // J Allergy Clin Immunol Pract. – 2022. – Vol. 10, No. 1. – P. 286–296.e3. – DOI: 10.1016/j.jaip.2021.10.033.

2. Primary Immunodeficiencies: A Decade of Progress and a Promising Future / I. Meyts [et al.] // Frontiers in Immunology. – 2021. – Vol. 11. – P. 625753. – DOI: 10.3389/fimmu.2020.625753.

3. Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients / G. Kindle [et al.]. – medRxiv. – 2025. – 16 Apr. – Article ID 2025.02.20.25322586. – DOI: 10.1101/2025.02.20.25322586. – Update in: Journal of Human Immunology. – 2025. – Vol. 1, No. 3. – P. e20250007. – DOI: 10.70962/jhi.20250007.

4. New tools for diagnosis of primary immunodeficiencies: from awareness to artificial intelligence / P. Soler-Palacín [et al.] // Frontiers in Immunology. – 2025. – Vol. 16. – Article 1593897. – DOI: 10.3389/fimmu.2025.1593897.

5. The German national registry for primary immunodeficiencies (PID) / B. Gathmann [et al.] // Clinical & Experimental Immunology. – 2013. – Vol. 173, No. 2. – P. 372–380. – DOI: 10.1111/cei.12105.

6. Clinical and epidemiological characteristics of patients with suspected primary immunodeficiency disorders attending Alexandria University Children´s Hospital / D. A. Heiba [et al.] // International Journal of Contemporary Pediatrics. – 2019. – Vol. 6, No. 5. – P. 1–6. – DOI: 10.18203/2349-3291.ijcp20192810.

7. Thymic hypoplasia induced by copy number variations contributed to explaining sudden infant death based on forensic autopsies / C. Chen [et al.] // Forensic Science International. – 2023. – Vol. 345. – P. 111741. – DOI: 10.1016/j.forsciint.2023.111741.

8. Walong, E. Primary immunodeficiency diagnosed at autopsy: a case report / E. Walong, E. Rogena, D. Sabai // BMC Research Notes. – 2014. – Vol. 7. – Article 425. – DOI: 10.1186/1756-0500-7-425.

9. Vorsteveld, E. E. Next-generation sequencing in the field of primary immunodeficiencies: current yield, challenges, and future perspectives / E. E. Vorsteveld, A. Hoischen, C. I. van der Made // Clinical Reviews in Allergy & Immunology. – 2021. – Vol. 61. – P. 212–225. – DOI: 10.1007/s12016-021-08881-0.

10. Beyond TREC: pivotal role of tandem TREC/KREC assay in Czech SCID NBS pilot programme / M. Bloomfield [et al.] // Pediatric Allergy and Immunology. – 2025. – Vol. 36, No. 5. – Article e70100. – DOI: 10.1111/pai.70100.

11. Determination of excision rings of T- and Bcell receptor DNA by real-time multiplex PCR : instructions for use / E. A. Polyakova [et al.]. – Minsk, 2020. – 24 p.

12. Lessons learned from five years of newborn screening for severe combined immunodeficiency in Israel / A. Lev [et al.] // The Journal of Allergy and Clinical Immunology: In Practice. – 2022. – Vol. 10, No. 10. – P. 2722–2731.e9. – DOI: 10.1016/j.jaip.2022.04.013.


Review

For citations:


Polyakova E.A., Zobikova O.L., Kupchinskaya A.N., Sakovich I.S., Belevtsev M.V., Naumchik I.V. Clinical significance of determining trec and krec markers in dried blood spots in children with severe infectious diseases complicated by fatal outcome. Medical and Biological Problems of Life Activity. 2026;(2):20-25. (In Russ.) https://doi.org/10.58708/2074-2088.2026-2(38)-20-25

Views: 7

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2088 (Print)